Table 1 The number of different kinds of VIGs in SARS-CoV-2, SARS-CoV and MERS-CoV.

From: Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development

Virus

DEG

DEP

DPP

DTP

DUP

P-PPI

SAP

Total

SARS-CoV-2

810

171

1987

111

267

1257

335

4228

SARS-CoV

1487

51

998

2488

MERS-CoV

8895

292

9038

  1. DEG differentially expressed genes; DEP differentially expressed proteins; DPP differentially phosphorylated proteins; DTP differentially translated proteins; DUP differentially ubiquitinated proteins; P-PPI proteins that participate in human-virus protein–protein interactions; SAP disease severity associated proteins.